+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-14Number of Pages: 102

Uterine Fibroids Treatment Market (Procedure Type - Endometrial Ablation, MRI Guided Procedures (Percutaneous Laser Ablation and Transcutaneous Focused Ultrasound), Hysterectomy (Abdominal, Vaginal, Laparoscopic, Robotic, and Hysteroscopic Morcellation), Myomectomy (Open, Laparoscopic, and Robotic), Uterine Artery Embolization, and Radiofrequency Ablation; End User - Hospitals and Ambulatory Surgical Centers - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : U.S. Uterine Fibroid Treatment Market

4. Market Overview
     4.1. Introduction
             4.1.1. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
             4.4.1. Drivers
             4.4.2. Restraints
             4.4.3. Opportunity
     4.5. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, 2014–2024
             4.5.1. Market Revenue Projections, 2014–2024
     4.6. Disease Epidemiology and Treatment
     4.7. Porter’s Five Force Analysis
     4.8. Market Outlook

5. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, by Procedure Type, 2016–2024
     5.1. Introduction & Definition
     5.2. Key Findings/Developments
     5.3. Market Value (US$ Mn) Forecast, by Procedure Type, 2016–2024
             5.3.1. Endometrial Ablation
             5.3.2. MRI Guided Procedures
             5.3.3. Hysterectomy
             5.3.4. Myomectomy
             5.3.5. Uterine Artery Embolization 
             5.3.6. Radiofrequency Ablation
             5.3.7. Others
     5.4. Procedure Type Comparison Matrix
     5.5. Market Attractiveness, by Procedure Type, 2016–2024

6. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, by Procedure Type Sub-segment, 2016–2024
     6.1. Market Value (US$ Mn) Forecast, by Procedure Type Sub-segment, 2016–2024
             6.1.1. MRI Guided Procedures
                      6.1.1.1. MRI-guided Percutaneous Laser Ablation
                      6.1.1.2. MRI Guided Transcutaneous Focused Ultrasound
             6.1.2. Hysterectomy
                      6.1.2.1. Abdominal Hysterectomy
                      6.1.2.2. Vaginal Hysterectomy
                      6.1.2.3. Laparoscopic Hysterectomy
                      6.1.2.4. Robotic Hysterectomy
                      6.1.2.5. Hysteroscopic Morcellation
             6.1.3. Myomectomy
                      6.1.3.1. Open Myomectomy
                      6.1.3.2. Laparoscopic Myomectomy
                      6.1.3.3. Robotic Myomectomy
     6.2. Market Attractiveness, by Procedure Type Sub-segment, 2016–2024

7. U.S. Uterine Fibroid Treatment Market Analysis and Forecasts, by End-user, 2016–2024
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value (US$ Mn) Forecast, by End-user, 2016–2024
             7.3.1. Hospitals
             7.3.2. Ambulatory Surgical Centers
     7.4. End-user Comparaison Matrix
     7.5. Market Attractiveness, by End-user 

8. U.S. Uterine Fibroid Treatment Procedure Volume Analysis and Forecasts – 2010–2015 & 2016–2024
     8.1. Endometrial Ablation
     8.2. MRI Guided Procedures
             8.2.1. MRI-guided Percutaneous Laser Ablation
             8.2.2. MRI Guided transcutaneous focused Ultrasound
     8.3. Hysterectomy
             8.3.1. Abdominal Hysterectomy
             8.3.2. Vaginal Hysterectomy
             8.3.3. Laparoscopic Hysterectomy
             8.3.4. Robotic Hysterectomy
             8.3.5. Hysteroscopic Morcellation
     8.4. Myomectomy
             8.4.1. Open Myomectomy
             8.4.2. Laparoscopic Myomectomy
             8.4.3. Robotic Myomectomy
     8.5. Uterine Artery Embolisation
     8.6. Radiofrequency Ablation
     8.7. Others

9. Competition Landscape
     9.1. Market Player – Competition Matrix (By Tier and Size of companies)
     9.2. Market Share Analysis, by Company (2015)
     9.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
             9.3.1. Blue Endo
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.2. Boston Scientific Corporation
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.3. CooperSurgical, Inc.
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.4. Karl Storz
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.5. Halt Medical, Inc.
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.6. LiNA Medical USA
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.7. Merit Medical Systems
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.8. Olympus Corporation
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies
             9.3.9. Richard Wolf GmbH
             9.3.1. Company Overview
             9.3.2. Financial Overview
             9.3.3. Business Strategies

List of Figures

Figure 01: US Uterine Fibroid Treatment Market Revenue (US$ Mn) Forecast, 2014–2024
Figure 02: U.S. Endometrial Ablation Market Revenue (US$ Mn), 2014–2024
Figure 03: U.S. MRI Guided Procedures Market Revenue (US$ Mn), 2014–2024
Figure 04: U.S. Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 05: U.S. Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 06: U.S. Endometrial Ablation Devices Market, Revenue (US$Mn), 2014–2024
Figure 07: U.S. Radiofrequency Ablation Devices Market, Revenue (US$ Mn), 2014–2024
Figure 08: U.S. Other Procedure Market, Revenue (US$Mn), 2014–2024
Figure 09: U.S. Uterine Fibroid Market Attractiveness Analysis, by Procedure Type, 2016 – 2024
Figure 10: U.S. MRI-guided Percutaneous Laser Ablation Market Revenue (US$ Mn), 2014–2024
Figure 11: U.S. MRI guided Transcutaneous Focused Ultrasound Market Revenue (US$ Mn), 2014–2024
Figure 12: U.S. Abdominal Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 13: U.S. Vaginal Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 14: U.S. Laparoscopic Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 15: U.S. Robotic Hysterectomy Market, Revenue (US$ Mn), 2014–2024
Figure 16: U.S. Hysteroscopic Morcellation Market, Revenue (US$ Mn), 2014–2024
Figure 17: U.S. Open Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 18: U.S. Laparoscopic Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 19: U.S. Robotic Myomectomy Market, Revenue (US$ Mn), 2014–2024
Figure 20: U.S. Uterine Fibroid Market Attractiveness Analysis, by Procedure Type Sub-segment, 2016 – 2024
Figure 21: U.S. Hospitals Market, Revenue (US$ Mn), 2014–2024
Figure 22: U.S. Ambulatory Surgical Centers Market, Revenue (US$ Mn), 2014–2024
Figure 23: U.S. Uterine Fibroid Market Attractiveness Analysis, by End-user, 2016 – 2024
Figure 24: U.S. Uterine Fibroid Treatment Market Share Analysis, by Company (2015)

List of Tables

Table 01: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by Procedure Type, 2014–2024
Table 02: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by MRI Guided Procedure Type, 2014–2024
Table 03: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by Hysterectomy Procedure Type, 2014–2024
Table 04: U.S. Uterine Fibroid Treatment Market Size (US$ Mn) Forecast, by Myomectomy Procedure Type, 2014–2024
Table 05: U.S. Uterine Fibroid Treatment Market Value (US$ Mn) Forecast, by End-user, 2014–2024
Table 06: U.S. Uterine Fibroid Treatment Market Forecast, by Procedure Type, 2010–2024


 
 
Back To Top